SCHEDULE 13G/A: Airsculpt Technologies Founder Aaron Rollins Discloses 25.3% Beneficial Ownership Stake
Beneficial Ownership Report
Dr. Aaron Rollins, founder of Airsculpt Technologies, Inc., has reported a beneficial ownership of 25.3% of the company's common stock as of December 31, 2024.
Summary
- Aaron Rollins, the reporting person, beneficially owns 14,669,675 shares of Airsculpt Technologies, Inc. common stock.
- This ownership represents 25.3% of the company's total outstanding common stock.
- The reported shares include 14,669,675 shares held directly by Dr. Rollins and an additional 66,842 shares underlying restricted stock units (RSUs) that are scheduled to vest within 60 days of December 31, 2024.
- The percentage of class (25.3%) is calculated based on 57,882,284 shares of Common Stock outstanding as of November 7, 2024, as reported in the Issuer's Form 10-Q, plus the 66,842 vesting RSU shares, totaling an aggregate of 57,949,126 shares.
- Dr. Rollins holds sole voting power and sole dispositive power over all 14,669,675 beneficially owned shares.
Sentiment
Score: 7
Explanation: The filing indicates a significant and stable ownership stake by a key individual, which is generally viewed positively as it aligns management interests with shareholders. However, it's a routine disclosure and doesn't contain new operational or financial performance data.
Positives
- The significant ownership stake of 25.3% by Dr. Aaron Rollins, a key individual and likely founder, indicates strong alignment of interests between management and shareholders.
- Dr. Rollins' sole voting and dispositive power over his substantial holdings suggests stable control and clear decision-making authority within the company's leadership.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The significant ownership stake by Dr. Aaron Rollins may provide confidence due to strong alignment of interests and stable control, potentially influencing investor perception positively.
Key Dates
| Date | Description |
|---|---|
| 2024-11-07 | Date as of which 57,882,284 shares of Common Stock were outstanding, as reported in the Issuer's Form 10-Q. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end date). |
| 2025-02-07 | Date the Schedule 13G Amendment No. 4 was signed and filed with the SEC. |
Keywords
Airsculpt Technologies, Aaron Rollins, Schedule 13G, beneficial ownership, common stock, equity stake, founder ownership, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.